CRTX - Cortexyme Inc
Close
1.95
0.050 2.564%
Share volume: 272,208
Last Updated: Fri 29 Jul 2022 10:00:01 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.90
0.05
2.63%
Summary score
9%
Profitability
0%
Dept financing
1%
Liquidity
50%
Performance
10%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 31-Dec-2015 - 31-Dec-2019
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-8.43%
Return on assets
-8.41%
Return on sales
0%
Return on invested capital
-241.51%
Total debt ratio
5.75%
Debt ratio change over timeo
-1.02%
Current Ratio
16.72%
Quick Ratio
0%
Cash Position Ratio
6.16%
Short-term ratios 31-Dec-2018 - 31-Dec-2019
The data are presented for the financials results of the quarters of the last year.
Return on equity
-8.43%
Return on assets
-8.41%
Return on sales
0%
Return on invested capital
-241.51%
Total debt ratio
5.75%
Debt ratio change over timeo
-1.02%
Current Ratio
16.72%
Quick Ratio
0%
Cash Position Ratio
6.16%
Last quarter ratios 31-Dec-2019
The data are presented for the financials results of the last quarter.
Return on equity
-10.72%
Return on assets
-10.41%
Return on sales
0%
Return on invested capital
-131.38%
Total debt ratio
7.15%
Debt ratio change over time
-1.02%
Current Ratio
11.93%
Quick Ratio
0%
Cash Position Ratio
5.76%
Performance ratios (change over 4 years) 31-Dec-2015 - 31-Dec-2019
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-96.68%
Return on assets
-96.68%
Return on sales
0%
Return on invested capital
26.01%
Total debt ratio
-102.27%
Debt ratio change over time
-1.02%
Current Ratio
-8.48%
Quick Ratio
0%
Cash Position Ratio
-3.72%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CRTX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -8.43% | 3.38% | 10.1% | 6.09% |
| Return on assets | -8.41% | 3.79% | 3.51% | 5.38% |
| Return on sales | 0% | 33.46% | 42.92% | 33.01% |
| Return on invested capital | -241.51% | 4.88% | 8.3% | 11.96% |
| Profitability | 0% | 56% | 84% | 84% |
| Total debt ratio | 5.75% | 100.22% | 71.21% | 29.5% |
| Debt ratio change over time | -1.02% | 14.95% | 5.12% | 1.7% |
| Dept financing | 1% | 50% | 26% | 10% |
| Current Ratio | 16.72% | 1.56% | 2.5% | 4.04% |
| Quick Ratio | 0% | 1.45% | 2.22% | 3.29% |
| Cash Position Ratio | 6.16% | 0.97% | 0.66% | 1.72% |
| Liquididy | 50% | 14% | 33% | 32% |
| Short-term ratios | CRTX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -8.43% | -24.18% | 18.55% | 5.09% |
| Return on assets | -8.41% | 4.92% | 3.95% | 4% |
| Return on sales | 0% | 37.6% | 41.32% | 27.89% |
| Return on invested capital | -241.51% | 7.93% | 10.38% | 10.86% |
| Profitability | 0% | 66% | 94% | 69% |
| Total debt ratio | 5.75% | 112.95% | 82.58% | 25.55% |
| Debt ratio change over time | -1.02% | 16.62% | 5.88% | 2.04% |
| Dept financing | 1% | 50% | 27% | 9% |
| Current Ratio | 16.72% | 1.56% | 2.5% | 4.04% |
| Quick Ratio | 0% | 1.45% | 2.22% | 3.29% |
| Cash Position Ratio | 6.16% | 0.97% | 0.66% | 1.72% |
| Liquididy | 50% | 17% | 23% | 38% |